| Literature DB >> 29538285 |
Sven Hoppe1, Christoph E Albers2, Tarek Elfiky3, Moritz C Deml4, Helena Milavec5, Sebastian F Bigdon6, Lorin M Benneker7.
Abstract
The aim of this study was to assess the performance of a new vacuum plasma sprayed (VPS) titanium-coated carbon/polyetheretherketone (PEEK) cage under first use clinical conditions. Forty-two patients who underwent a one or two segment transforaminal lumbar interbody fusion (TLIF) procedure with a new Ca/PEEK composite cage between 2012 and 2016 were retrospectively identified by an electronic patient chart review. Fusion rates (using X-ray), patient's satisfaction, and complications were followed up for two years. A total of 90.4% of the patients were pain-free and satisfied after a follow up (FU) period of 29.1 ± 9 (range 24-39) months. A mean increase of 3° in segmental lordosis in the early period (p = 0.002) returned to preoperative levels at final follow-ups. According to the Bridwell classification, the mean 24-month G1 fusion rate was calculated as 93.6% and the G2 as 6.4%. No radiolucency around the cage (G3) or clear pseudarthrosis could be seen (G4). In conclusion, biological properties of the inert, hydrophobic surface, which is the main disadvantage of PEEK, can be improved with VPS titanium coating, so that the carbon/PEEK composite cage, which has great advantages in respect of biomechanical properties, can be used safely in TLIF surgery. High fusion rates, good clinical outcome, and low implant-related complication rates without the need to use rhBMP or additional iliac bone graft can be achieved.Entities:
Keywords: PEEK; cage; composite; lumbar fusion; spine; titanium-coated carbon
Year: 2018 PMID: 29538285 PMCID: PMC5872109 DOI: 10.3390/jfb9010023
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Segmental, caudal adjacent, cranial adjacent, and global lordosis preoperative, six months postoperative, and at latest FU, and degeneration at adjacent segment pre-OP and at latest FU; * (p > 0.05).
| Pre-OP | Six Months Post-OP | Latest FU | |
|---|---|---|---|
|
| |||
| Segmental lordosis (range) | 9° (0–14°) | 12° (7–16°) * | 10° (2–15°) |
| Caudal adjacent lordosis | 10° (8–15°) | 10° (7–15°) | 10° (7–15°) |
| Cranial adjacent lordosis | 11° (7–14°) | 11°(7–14°) | 11° (7–15°) |
| Lumbar lordosis L1–S1 | 52° (41–63°) | 53° (41–63°) | 53° (41–63°) |
|
| |||
| G0 (n) | 15 | 14 | 13 |
| G1 (n) | 38 | 39 | 36 |
| G2 (n) | 15 | 15 | 14 |
| G3 (n) | 4 | 4 | 11 * |
Complications with respective operation level, post-operative interval until onset of symptoms, treatment, and result are listed for each patient.
| Patient | Age (Years) | Operation Level | Post-Operative Interval (Days) | Complications | Treatment | Results |
|---|---|---|---|---|---|---|
| 1 | 55 | L4–5 | 5 | Seroma | Clinical Observation | Resolved without intervention |
| 2 | 29 | L5–S1 | 4 | Hyposensibility | Steroid | 2 months later resolved |
| 3 | 65 | L3–4 | 11 | Hematoma | Clinical Observation | Resolved without intervention |
| 4 | 54 | L3–4 | 3 | Deep infection | 5 times debridement + antibitherapy | Fully recovered |
| 5 | 69 | L4–5 | 5 | L5 right partial motor deficit | Steroid | Resolved without intervention |
| 6. | 67 | L4–5 | 4 | L5 right partial motor deficit | Steroid | Resolved without intervention |
| 7 | 78 | L5–S1 | 8 | Wound disorder | Clinical Observation | Resolved without intervention |
| 8 | 63 | L3–4 | 4 | L5 right paraesthisia | Steroid | Resolved without intervention |
| 9 | 41 | L5–S1 | 9 | L4–5 partial motor deficit + paraesthisia | Steroid | Persisting L4–5 hyposensibility + decreased force (M4) |
| 10 | 63 | L3–4 | 9 | Lung embolia | Medical treatment | Fully recovered |
| 11 | 28 | L4–S1 | 4 | L5 right paraesthisia | Steroid | Paraesthisia |
| 12 | 62 | L3–4 | 8 | L2–3 partial motor deficit + L5 paraesthisia | Steroid | L2–3 M4 |
Patients’ demographics.
| Parameter | Value |
|---|---|
| Number of patients (levels) | 42 (47) |
| Patients lost to follow-up (%) | 27 |
| Multiple level fusion (%) | 5 (12) |
| Mean age (range) | 59.6 (28–82) |
| Male (%) | 23 (55) |
| Mean BMI (± SD, range; kg) | 28.3 ± 5 (19–40) |
| Mean time of follow-up (± SD, range; months) | 29.1 ± 9 (24–39) |
| Diagnosis | |
| Spinal stenosis (%) | 26 (62) |
| Degenerative spondylolisthesis (%) | 11 (26) |
| - Meyerding I (%) | 7 (63) |
| - Meyerding II (%) | 4 (37) |
| - Meyerding III (%) | - |
| - Meyerding IV (%) | - |
| Isthmic spondylolisthesis (%) | 2 (5) |
| Recurrent degenerative disc disease (%) | 3 (7) |
| Level with fusion | |
| L2–3 (%) | 9 |
| L3–4 (%) | 17 |
| L4–5 (%) | 23 |
| L5–S1 (%) | 51 |
Figure 1E-turn cage.
Figure 2anterior–posterior (right) and lateral (left) X-ray of an 40 year old woman after TLIF surgery with percutaneous dorsal instrumentation and implantation of the newly-developed cage at the level L4/5, one-year FU.
Bridwell interbody fusion grading system grade description.
| I | Fused with remodeling and trabeculae present |
| II | Graft intact, not fully remodeled and incorporated, but no lucency present |
| III | Graft intact, potential lucency present at top and bottom of graft |
| IV | Fusion absent with collapse/resorption of graft |
Parameters (and scores) on plain anteroposterior and lateral radiographs; disc height, osteophytes, and calcifications correlated significantly with degeneration.
| Grade | Height Loss | Osteophytes | Schmorl’s Nodes | Intradiscal Calcification | Sclerosis | Endplate Shape |
|---|---|---|---|---|---|---|
| 0 | 0–10% | Margins rounded | Not present | No calcifications | None | Continuous |
| 1 | 10–20% | Margins pointed | Present | Rim calcification | Moderate | Irregular |
| 2 | 20–30% | <2 mm | - | Intranuclear calcification | Severe | Disrupted |
| 3 | >30% | >2 mm | - | - | - | - |
Figure 3Normalized foraminal height was evaluated by dividing the measured foraminal height F through the height of the vertebral body D just beyond, according to the formula Fnorm = F/D. Measurement of the normalized segmental height Snorm = δ/D.